1/71
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
what was propranol introduced to treat
hypertension
angina
cardiac arrythmias
what is a side effect of propranol
corneal anesthesia
what is a side effect of practolol
immunological problems (oculomucocutaneous syndrome)
what does beta 1, 2 and 3 stimulation cause
beta 1: increase heart rate, cardiac contractility & artroventricular conduction
beta 2: dilation of bronchi & blood vessels
beta 3: mediation of lipolysis
selectivity is relative at ___ concentrations selective beta-adrenergic act on __ beta receptors
high; all
what is the mechanism of action of ocular beta blockers
reduction in aqueous formation (no change in outflow facility)
what is the classic hypothesis on the mechanism of ocular beta blockers
beta blockers inhibits beta adrenergic agonists from binding to its receptors stopping the activation of G-protein, which stops formation of cAMP
what is the evidence against the classic hypothesis
IOP can decrease in response to increase in cAMP
both dextro & levo isomer of timolol decrease IOP (evidence against competitive inhibition)
what is the alternate hypothesis of the mechanism of OBBs
ciliary process are under continuous tonic stimulation to produce aqueous & beta blockers interfere with the tonic stimulation
(no anatomic basis identified yet)
If the amount of drug is not limited how much aqueous humor suppression can occur due to beta blockers?
50%
contraindications of beta blockers
pulmonary disease, bronchial asthma, COPD
sinus bradycardia
overt congestive heart failure
hypersensitivity
which OBB is not contraindicated for pulmonary diseases?
betaxolol
what is the treatment regimen for OBB
once or twice daily in the morning
twice daily may lower IOP more but more side effects
what OBB are the exceptions to taking OBBs twice daily
isatalol QAM
timoptic XE or GFS (gels) qd
betagan qd
which concentration is most commonly used for ocular beta blockers?
0.5%
when would 0.25% concentration of OBBs be used?
if pt has history of asthma or bradycardia
children
why is BAK commonly used in OBBs?
allows it to penetrate corneal epithelium
timolol characteristics
non selective beta adrenergic antagonist
no corneal anesthesia (like propranolol)
greater efficacy than pilocarpine
what is the onset & peak action of timolol
onset: 30 mins
peak: 2 hrs
max: 12 hr & continues lowering for 24 hrs
what is short term escape
efficacy of timolol decreases over time (several weeks)
response of beta receptors to constant antagonist
may be an up regulation of beta receptors in target tissue
what is long term drift
over months to years
control of IOP not as good as once
washing out & re starting helps
how long is a wash out period for
2-6 weeks (clinically 4 weeks)
advantages & disadvantages of gels
advantages: improve bioavailability; decrease systemic absorption
disadvantage: blurs vision if left over in morning
what is timoptic XE preserved with?
benzododecinium bromide
characteristics of istalol (timolol maleate 0.5%)
formulated with potassium sorbate
claims to enhance bioavailability (once daily)
lower BAK concentration
on istalol most visits IOP difference is within __ mm Hg & all visits are within __ mm Hg
1 mm hg; 1.5 mm hg
what was the initial and later concentration of betaxolol hydrochloride
initial: 0.5% solution
later: 0.25% suspension of resin coated beads
what are the advantages and disadvantages of betaxolol suspension (betoptic S)
advantage: less ocular irritation than solution; can be used in patients with pulmonary disease; lower CNS effects
disadvantage: less effective than timolol
is betaxolol lipophilic or hydrophilic
lipophilic (binds well with plasma proteins)
how does betaxolol have neuroprotectic effect
possess calcium channel blocker properties (if Ca enters cells it causes apoptosis)
local side effects of OBBs
discomfort
burning
stinging
what ocular side effects of OBBs does BAK make worse
decreased tear production
decreased goblet cell density
ocular cicatricial pemphigoid
dry eye symptoms
metipranolol is associated with what ocular side effect
granulomatous uveitis
OBBs enter systemic circulation via __
nasolacimral system
peak vs trough plasma levels of OBBs
peak: 50-103 ng/milliliter
trough: 0.8-7.2 ng/milliliter
plasma levels of timolol
5.0-9.6 ng/milliliter
CNS adverse effects of OBBs
anxiety, depression, fatigue, lethargy, confusion, sleep disturbance, memory loss & dizziness
decreased libido men & women
impotence in men
cardiovascular adverse effects of OBBs
lower heart rate
lower bp
decreased myocardial contractility
slowed conduction time
metabolic adverse effects of OBBs
affects lipid metabolism
timolol: 12% increase in triglycerides; 9% decrease in HDL
what systemic condition may beta blockers mask
diabetes hypoglycemia
what are types adrenergic agents
clonidine
apraclonidine
brimonidine
clonidine adverse effects
sedation
systemic hypotension
narrow therapeutic index
apraclonidine characteristics
hydrophilic: does not penerate eyes & BBB
more alpha2 selective
wide therapeutic index
mechanism of action of apraclonidine
decreased aqueous production
improves trabecular outflow
decreased episcleral venous pressure
uses of apraclonidine
FDA approved to prevent post laser treatment spikes in IOP
Adjunctive therapy
mechanism of action of brimonidine
alpha 2 selective: reduction of aqueous production by activation of G-protein receptor, decreased cAMP & production of aqueous humor
peak effectiveness of brimonidine
2 hours
indications for bimonidine
prophylactic to avoid post laser IOP spike
primary or secondary therapy glaucoma & ocular hypertension
contraindications of brimonidine
MAOI bc may interfere with the metabolism of brimonidine and increase systemic side effects (hypotension)
children
adverse effects of brimonidine
conjunctival follicles, ocular allergic reactions and ocular pruritus
headache, blurring, foreign body sensation, sensation/drowsiness
oral dryness
ocular hyperemia, burning & staining
rho kinase inhibitors mechanism of action
changes to trabecular meshwork: cytoskeletal modulating drugs
netarsudil (rhopressa) mechanisms of action
primary: alter TM cells to allow aqueous humor to leave
secondary: changes episcleral venous pressure by making it lower, which causes less resistance for aqueous to leave
tertiary: alters NE transporter to lower aqueous production
what do MLCP and MLCK do to TM
MLCK causes TM to go into phosphorylated stage (contraction)
MLCP causes TM to go into dephosphorylated stage (relaxed)
what does netarsudil do to rho kinase
rho kinase inhibits MLCP (stops TM from relaxing)
netarsudil inhibits rho kinase
dosing of netarsudil
once daily in the evening
netarsudil adverse effects
conjunctival hyperemia
cornea verticillata: decreases contrast not VA
corneal erosions, changes in endothelium
conjunctival hemorrhage
lacrimation increased
how does netarsudil cause cornea verticillate
leaves a lipid sugar byproduct in lysosomes
what is netarsudil combined with that causes better IOP lowering than it alone?
latanoprost (roclatan)
mechanism of action cholinergic agents
contraction of ciliary muscle causes unfolding of meshwork & widening of schlemm's canal
cytoskeleton modulating drug
pilocarpine dosing schedule
drops: QID
gel: bed time
drug concentration of pilocarpine needed for light vs dark irises
light: 2%
dark: 6%
strength of pilocarpine
10-30 mins onset
max IOP reduction: 75 mins
lasts 4-8 hr
IOP lowering 4-14 hrs
side effects of pilocarpine
stinging, burning
prolonged use: risk of failure with surgeries (hyphema)
ciliary spasm, temporal or supraorbital headache & induced myopia
pupillary block
miosis: decrease VA
cause of long term escape of pilocarpine
increasing problems in drainage mechanism
systemic toxicity of pilocarpine
sweating
salivation & lacrimation
gastrointestinal
contraindications of pilocarpine
risk/history of retinal detachment
intraocular congestion like uveitis
any one whom pupil size & accommodation is an issue
what drugs can you combine pilocarpine with
combined with drugs that decrease aqueous humor production (beta blockers, carbonic anhydrase inhibitors)
what do carbonic anhydrase inhibitors do
reduction of bicarbonate ions in posterior chamber that subsequently prevents Na+ movement & hence water movement
dosage of oral carbonic anhydrase inhibitors
acetazolamide max dose 250 mg qid
methazolamide max dose 150 mg bid
contraindications of carbonic anhydrase inhibitors
sulfa allergies
DM susceptible to ketoacidosis
hepatic insufficiency & cannot tolerate the increase in serum ammonia
chronic obstructive pulmonary disease who increase retention of carbon dioxide can cause narcosis
low endothelial cell count
side effects of CAIs
numbness, paresthesias, malaise, anorexia, nausea, flatuelnce, diarrhea, depression, decreased libido, hirsutism, serum urate
durysta (bimatoprost) sustained release implants
releases a pellet & goes to inferior region & slowly releases but can only do it once because over time can cell loss